Market Cap (In TWD)
3.64 Billion
Revenue (In TWD)
25.84 Million
Net Income (In TWD)
-337.98 Million
Avg. Volume
334.04 Thousand
- Currency
- TWD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 23.6-34.6
- PE
- -
- EPS
- -
- Beta Value
- 0.328
- ISIN
- TW0006461007
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Mr. Wei-Shiu Wu
- Employee Count
- -
- Website
- https://www.intechbiopharm.com
- Ipo Date
- 2014-07-15
- Details
- Intech Biopharm Corporation engages in developing and manufacturing generic drugs to treat respiratory diseases in Taiwan and internationally. It owns iLEF (inhaled low ethanol formulation), a metered dose inhaler platform for treating asthma and COPD; and dry powder inhaler, a product comprises of blisters and capsules. The company offers its products under the SYN006, SYN010, SYN007, Synflutide, Duasma, Synvent, and SYN011 names. Intech Biopharm Corporation was founded in 2010 and is headquartered in Taipei, Taiwan.
More Stocks
-
TR1
-
BIGBig Lots, Inc.
BIG
-
PECO
-
M7T
-
BRSR3
-
CDAB
-
6197
-
1223